Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Sekijima, Y.
space
  arrow  Yanagisawa, N.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Follow-up of Sarin Poisoning in Matsumoto

right arrow Yoshiki Sekijima, MD, PhD; Hiroshi Morita, MD, PhD; and Nobuo Yanagisawa, MD, PhD

1 December 1997 | Volume 127 Issue 11 | Page 1042


TO THE EDITOR:

The sarin (isopropyl methyl phosphonofluoridate) attack in Matsumoto, Japan, killed 7 residents and poisoned approximately 500 others [1]. Although widespread health hazards occurred during the acute phase [1-3], there are few data on the sequelae of sarin exposure [4, 5]. To explore the long-term effects of sarin on humans, we conducted 1-year and 2-year follow-up health examinations of all victims who showed a decrease in serum cholinesterase (ChE) activity or miosis during the acute phase.

One hundred forty-nine victims met these criteria and 85 (57.0%) had these examinations. We classified them into 3 groups according to the percentage of the minimum value for normal ChE (ChE%) in the acute phase. There were 6 persons in the severely poisoned group (ChE% < 25%), 27 in the moderately poisoned group (ChE%, 25% to <100%), and 52 in the mildly poisoned group (ChE% ≥ 100% or not examined). All severely poisoned victims still showed abnormal findings (Table 1). We found that 4 of 6 severely poisoned persons (patients 1 to 4) still showed epileptic electroencephalographic changes, which were the most characteristic abnormality. Other abnormal findings, such as arrhythmia, hypoxia, or low-grade fever, also continued to be seen in the severely poisoned group (patients 1, 5, and 6). One of the severely poisoned victims (patient 2) developed sensory polyneuropathy 7 months after the exposure, and sensory nerve conduction velocity was reduced. In the moderately poisoned group, although 1 victim continued to have visual field defects at the 1-year follow-up health examination, he recovered completely 17 months after the exposure (patient 7). The other moderately poisoned victims and all of the mildly poisoned victims showed no objective abnormal findings. We conclude that exposure to high levels of sarin gas carries a risk for sequelae.


View this table:
[in this window]
[in a new window]
 
Table 1. Follow-up Examinations in One Mildly Sarin-Poisoned and Six Severely Sarin-Poisoned Patients*

 


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Shinsu University School of Medicine; Matsumoto 390, Japan


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Morita H, Yanagisawa N, Nakajima T, Shimizu M, Hirabayashi H, Okudera H, et al. Sarin poisoning in Matsumoto, Japan. Lancet. 1995; 346:209-3.

2. Suzuki T, Morita H, Ono K, Maekawa K, Nagai R, Yazaki Y. Sarin poisoning in Tokyo subway [Letter]. Lancet. 1995; 345:980.

3. Nozaki H, Alkawa N, Shinozawa Y, Hori S, Fujishima S, Takuma K, et al. Sarin poisoning in Tokyo subway [Letter]. Lancet. 1995; 345:980-1.

4. Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol. 1979; 47:161-76.

5. Sekijima Y, Morita H, Shindo M, Okudera H, Shibata T, Yanagisawa N. [A case of severe poisoning in the sarin attack in Matsumoto. One-year follow-up of clinical findings, and laboratory data.] Rinshoshinkeigaku. 1995; 35:1241-5.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Sekijima, Y.
space
  arrow  Yanagisawa, N.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online